|
It has been 20 years since Neuland set out on its strengths of unique competencies in pharmaceutical chemistry and on a vision, which recognized ethics, transparency and long - term bonds. An approach that has become the cornerstone of its growth. Translating every little strength into an opportunity, Neuland has grown to become one of the most reliable API source for the Pharma Industry. Today, the company is the preferred partner to leading pharma majors in around 75 countries with close to Rs. 1470 million turnover.
From a single product company to a global player with a diversified product mix and multi - locational facilities, Neuland has established its strengths and competencies. Unmatched quality, timely delivery and strict adherence to standards like cGMP and ICH guidelines lend more flexibility to Neuland's profile. It is Neuland's commitment to such practices that has enabled long - term relationships with customers in India and around the world.
Neuland has two world - class manufacturing facilities close to the city of Hyderabad ( India ). Both facilities are USFDA "systems" inspected. The facilities certified by WHO-cGMP standards, EDQM and TGA. Capable of a comprehensive gamut of reactions including Bromination, Diazotization, Friedel - Craft, Hydrogenation, Mannich, Grignard, Metal Hydride reduction, Oxidation and Cryogenic reactions.
Neulands multi-product manufacturing facilities at Bonthapally and Pashamylaram are inspected and approved by USFDA and both the units also boast GMP approval from TGA, Australia. Neuland has been accredited with COS from EDQM for eight of its API's across five therapeutic categories. Neuland with 20 Active USDMF' s and more than 150 DMF filings with various Health Authorities across Europe and other regulated markets is testimony enough to Neuland's unrelenting commitment for being and continuing to be a preferred source worldwide.
|
